Please find enclosed herewith intimation of closure of trading window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has informed the BSE that its trading window for dealing in company shares will be closed starting January 1, 2026. The closure is mandatory under SEBI's insider trading rules because the company is preparing to announce its unaudited financial results for the quarter ending December 31, 2025. The window will reopen 48 hours after the financial results are publicly disclosed. During this period, directors, employees, key managerial personnel, designated persons, and their immediate relatives are prohibited from trading in the company's shares or securities.
This is a routine, compliance-driven disclosure and does not carry any direct impact on shareholders or the stock price. It simply means insider-related trades are paused until the Q3 FY26 results are announced, which is a standard pre-earnings blackout practice.